Download PDF
Klin Monbl Augenheilkd 2020; 237(04): 425-426
DOI: 10.1055/a-1068-2735
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Bilateral Acute Anterior Uveitis during Chemotherapy with Cytosine Arabinoside with a Total Cumulative Dose of 24 000 mg for Myelodysplastic Syndrome

Bilaterale akute anteriore Uveitis während der Chemotherapie von Cytosin-Arabinosid mit einer kumulativen Gesamtdosis von 24 000 mg für das myelodysplastische Syndrom
Celine Noha Isabelle Häller
1   Jules Gonin Eye Hospital, Ophthalmology Department, University of Lausanne, Lausanne, Switzerland
,
Yalda Sadeghi
1   Jules Gonin Eye Hospital, Ophthalmology Department, University of Lausanne, Lausanne, Switzerland
,
Malik Benmachiche
2   Department of internal medicine, Lausanne University Hospital, Lausanne, Switzerland
,
Yan Guex-Crosier
1   Jules Gonin Eye Hospital, Ophthalmology Department, University of Lausanne, Lausanne, Switzerland
› Author Affiliations
Further Information

Publication History

received 26 September 2019

accepted 14 November 2019

Publication Date:
24 April 2020 (online)

Also available at
    Permissions and Reprints

Background

We report one case of uveitis secondary to a treatment with cytosine arabinoside (Ara-C).

 

  • References

  • 1 Grewal DS, Holland PM, Frankfurt O. et al. Asymmetric anterior uveitis as a delayed complication of treatment with systemic high-dose cytosine-arabinoside: a case report and literature review. Ocul Immunol Inflamm 2014; 22: 322-325
    CrossrefPubMedGoogle Scholar
  • 2 Moberg J, Carlsson M, Holm C. et al. Severe anterior uveitis as a complication of high-dose cytosine-arabinoside. Acta Ophthalmol 2009; 87: 922-923
    CrossrefPubMedGoogle Scholar
  • 3 Döhner H, Esthey E, Grimwade D. et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017; 129: 424-447
    CrossrefPubMedGoogle Scholar
  • 4 Ritch PS, Hansen RM, Heuer DK. Ocular toxicity from high-dose cytosine arabinoside. Cancer 1983; 51: 430-432
    CrossrefPubMedGoogle Scholar
  • 5 Planer D, Cukierman T, Liebster D. et al. Anterior uveitis as a complication of treatment with high dose cytosine-arabinoside. Am J Hematol 2004; 76: 304-306
    CrossrefPubMedGoogle Scholar
  • 6 Higa GM, Gockerman JP, Hunt AL. et al. The use of prophylactic eye drops during high-dose cytosine arabinoside therapy. Cancer 1991; 68: 1691-1693
    CrossrefPubMedGoogle Scholar